Vertex Pharmaceuticals Incorporated VRTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

84/100

5/7 Pass

SharesGrow Intrinsic Value

There have been 50 recent insider transactions recorded for Vertex Pharmaceuticals Incorporated (VRTX), including 1 buy and 48 sells. Total insider buying was valued at RSU Award and total insider selling at $50.44M.

Notable insiders with recent activity include Liu Joy, Bozic Carmen, Mckechnie Duncan. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — VRTX

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2026-04-01	Liu Joy	EVP and Chief Legal Officer	Informative Sell	978	$449.17	$439.29K	21,833
2026-03-27	Bozic Carmen	EVP and CMO	Informative Sell	2,329	$450.95	$1.05M	33,076
2026-03-13	Bozic Carmen	EVP and CMO	Informative Sell	2,329	$481.79	$1.12M	35,405
2026-03-11	Mckechnie Duncan	EVP, Chief Commercial Officer	Informative Sell	2,633	$498.42	$1.31M	12,489
2026-03-04	Mckechnie Duncan	EVP, Chief Commercial Officer	Informative Sell	2,437	$475.30	$1.16M	15,122
2026-03-02	Liu Joy	EVP and Chief Legal Officer	Informative Sell	892	$495.96	$442.4K	22,811
2026-03-01	Liu Joy	EVP and Chief Legal Officer	Unknown	7,044	$155.57	$1.1M	-
2026-02-27	Kewalramani Reshma	CEO & President	Informative Sell	1,725	$496.95	$857.24K	98,278
2026-02-27	Bozic Carmen	EVP and CMO	Informative Sell	2,329	$480.31	$1.12M	37,734
2026-02-26	Ambrose Kristen	SVP & Chief Accounting Officer	Informative Sell	357	$483.36	$172.56K	6,624
2026-02-25	Sachdev Amit	EVP Chief Patient & Ext Af Off	Informative Sell	1,846	$486.35	$897.8K	55,570
2026-02-25	Biller Jonathan	EVP and Chief Legal Officer	Informative Sell	945	$486.35	$459.6K	13,659
2026-02-25	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Informative Sell	260	$486.35	$126.45K	46,763
2026-02-25	Ambrose Kristen	SVP & Chief Accounting Officer	Informative Sell	223	$486.35	$108.46K	6,981
2026-02-25	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Informative Sell	668	$486.35	$324.88K	18,432
2026-02-25	Mckechnie Duncan	EVP, Chief Commercial Officer	Informative Sell	2,410	$489.00	$1.18M	17,559
2026-02-25	Bunnage Mark E.	EVP, Chief Scientific Officer	Informative Sell	620	$486.35	$301.54K	7,284
2026-02-24	Wagner Charles F Jr	EVP, Co & Fo	Tax Withholding of RSU	1,744	$485.11	$846.03K	47,042
2026-02-24	Leiden Jeffrey M	Executive Chairman	Tax Withholding of RSU	3,547	$485.11	$1.72M	34,797
2026-02-24	Sachdev Amit	EVP Chief Patient & Ext Af Off	Tax Withholding of RSU	1,518	$485.11	$736.4K	57,416
2026-02-24	Kewalramani Reshma	CEO & President	Tax Withholding of RSU	4,981	$485.11	$2.42M	138,278
2026-02-24	Biller Jonathan	EVP and Chief Legal Officer	Tax Withholding of RSU	1,144	$485.11	$554.97K	14,604
2026-02-24	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Tax Withholding of RSU	1,627	$485.11	$789.27K	47,023
2026-02-24	Bozic Carmen	EVP and CMO	Tax Withholding of RSU	1,453	$485.11	$704.86K	40,063
2026-02-24	Ambrose Kristen	SVP & Chief Accounting Officer	Tax Withholding of RSU	546	$485.11	$264.87K	7,204
2026-02-24	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Tax Withholding of RSU	1,627	$485.11	$789.27K	19,100
2026-02-24	Mckechnie Duncan	EVP, Chief Commercial Officer	Tax Withholding of RSU	873	$485.11	$423.5K	22,469
2026-02-24	Bunnage Mark E.	EVP, Chief Scientific Officer	Tax Withholding of RSU	582	$485.11	$282.33K	7,904
2026-02-19	Sachdev Amit	EVP Chief Patient & Ext Af Off	Option Exercise (Sell)	25,026	$187.53	$4.69M	-
2026-02-18	Leiden Jeffrey M	Executive Chairman	Tax Withholding of RSU	2,964	$483.75	$1.43M	38,344
2026-02-18	Biller Jonathan	EVP and Chief Legal Officer	Informative Sell	1,244	$473.68	$589.26K	15,748
2026-02-18	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Informative Sell	368	$473.68	$174.31K	48,650
2026-02-18	Ambrose Kristen	SVP & Chief Accounting Officer	Informative Sell	638	$473.68	$302.21K	7,750
2026-02-18	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Informative Sell	817	$473.68	$387K	20,727
2026-02-18	Bunnage Mark E.	EVP, Chief Scientific Officer	Informative Sell	1,182	$473.68	$559.89K	8,486
2026-02-17	Wagner Charles F Jr	EVP, Co & Fo	Tax Withholding of RSU	2,294	$483.75	$1.11M	48,786
2026-02-17	Leiden Jeffrey M	Executive Chairman	RSU Award	8,269	-	-	41,308
2026-02-17	Sachdev Amit	EVP Chief Patient & Ext Af Off	Tax Withholding of RSU	2,140	$483.75	$1.04M	69,042
2026-02-17	Kewalramani Reshma	CEO & President	Tax Withholding of RSU	6,554	$483.75	$3.17M	143,259
2026-02-17	Biller Jonathan	EVP and Chief Legal Officer	Informative Sell	2,476	$489.46	$1.21M	16,992
2026-02-17	Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Informative Sell	609	$489.46	$298.08K	49,018
2026-02-17	Bozic Carmen	EVP and CMO	Tax Withholding of RSU	1,912	$483.75	$924.93K	41,516
2026-02-17	Ambrose Kristen	SVP & Chief Accounting Officer	Informative Sell	1,557	$489.46	$762.09K	8,388
2026-02-17	Atkinson Edward Morrow Iii	EVP, Chief Technical Ops. Off.	Informative Sell	2,031	$489.46	$994.09K	21,544
2026-02-17	Mckechnie Duncan	EVP, Chief Commercial Officer	Tax Withholding of RSU	1,148	$483.75	$555.35K	23,342
2026-02-17	Bunnage Mark E.	EVP, Chief Scientific Officer	Informative Sell	2,437	$489.46	$1.19M	9,668
2026-02-13	Wagner Charles F Jr	EVP, Co & Fo	Tax Withholding of RSU	4,565	$487.76	$2.23M	43,715
2026-02-13	Sachdev Amit	EVP Chief Patient & Ext Af Off	Tax Withholding of RSU	3,548	$487.76	$1.73M	65,393
2026-02-13	Bhatia Sangeeta N.	Director	Informative Sell	266	$500.00	$133K	4,299
2026-02-13	Kewalramani Reshma	CEO & President	Tax Withholding of RSU	13,041	$487.76	$6.36M	133,487

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry